Dechra Veterinary Products has launched TAF Spray (thiamphenicol), a next generation antibiotic wound spray for superficial wound infections in horses, cattle, goats, sheep and pigs.
Dechra says TAF Spray can also be used to treat infections of the claw and hoof in cattle, goats and sheep such as foot rot, interdigital dermatitis and digital dermatitis.
TAF Spray is the only licensed wound spray for horses and has a zero day meat withdrawal period for horses, cattle, goats, sheep, and 14 days for pigs.
Dechra is also highlighting the fact that TAF Spray is the only golden yellow coloured product of its kind on the market, allowing treatment areas to be distinguished clearly.
Brand Manager Emma Jennings said: “Dechra has developed TAF Spray in direct response to the research we conducted among farmers".
The research1 showed that 51% of the veterinary surgeons had used an antibiotic spray for the treatment of digital dermatitis – an infection that 92% of farmers had experienced in their livestock in the past 12 months.
Emma added: "Thiamphenicol is a highly effective antibiotic. With the brightly coloured spray format making it distinguishable from other treatments and a can that is able to be used in upright and inverted positions, we are sure that TAF Spray will become a popular product among veterinary professionals.”
TAF Spray comes in a 150ml can with a 360-degree nozzle which allows wounds to be targeted at any angle.
For further information about Dechra’s antibiotic portfolio, visit www.dechra.co.uk
Reference
Metacam 40 mg/ml solution for injection for cattle and horses contains 40 mg/ml of meloxicam, and is available in either 50 ml or 100 ml presentations. It is approved for subcutaneous or intravenous use in cattle, and intravenous use in horses.
Boehringer says the introduction comes on the back of a recent large-scale landmark study that found adding Metacam to standard antibiotic therapy for mastitis resulted in a greater first-service conception rate, fewer inseminations required to conceive and a higher probability of pregnancy by 120 days post-calving when compared to cows receiving antibiotic therapy alone1.
Boehringer Ingelheim’s technical manager Kath Aplin said: "By reducing the pain and inflammation caused by mastitis and other conditions, the use of Metacam 40 can result in improvements in cattle health and welfare, and may help limit any reduction in feed intakes. This is central to efficient herd management and productivity."
The company adds that new Metacam 40 mg/ml formulation offers a lower volume dose compared to the existing 20 mg/ml presentation, giving vets more flexibility in their use of Metacam.
Boehringer Ingelheim Vetmedica has launched Buscopan 20mg/ml injection, an antispasmodic treatment for use in cases of equine colic, and an aid to the symptomatic treatment of calf scour.
A sister product to Buscopan Compositum which contains both an antispasmodic and a non-steroidal component, Buscopan 20 contains only the antispasmodic component - hyoscine butylbromide.
Craig Beck, equine sales and marketing manager at Boehringer Ingelheim Vetmedica said: "Our customers have been telling us for some time that they would really welcome a Buscopan formulation without an NSAID for use in horses and cattle. I'm pleased to say that it's finally here and I'm sure that Buscopan 20 will be a very welcome addition to the armoury of both equine and cattle practitioners."
Buscopan 20 is supplied in a 50ml multi-dose bottle, and is available in veterinary wholesalers now.
For further information, please call 01344 746959.
Tialin is licensed for the treatment of dysentery, colitis, ileitis, pneumonia and pleuropneumonia in pigs. It is also suitable for the treatment and metaphylaxis of chronic respiratory disease and infectious synovitis in chickens and infectious sinusitis and airsacculitis in turkeys. Withdrawal times range from zero in eggs to two - six days in meat and offal.
The product is available in two strengths: 25% (250 mg/ml) and 12.5% (125 mg/ml). It can be bought in five and one litre bottles with a shelf life of two years or three months once opened.
Dechra Brand Manager Emma Jennings said: "Any of these diseases could have a widespread effect on a herd or flock of any size so it is vital that veterinary professionals have access to a treatment such as Tialin to offer farmers.
"Its short withdrawal times and long shelf life makes it a cost effective and valuable tool for vets and farmers in their treatments of these diseases. All the products in our premium SoluStab range have been specifically developed with a unique formula to provide the optimum balance of stability and solubility."
For more information, visit www.dechra.co.uk/therapy-areas/food-producing-animal/water-medication.
Dechra also offers an online tool to calculate dosage for SoluStab products at http://calculator.solustab.eu/.
Registered VN Lindsay Newell has been found guilty of six counts of cruelty to animals at Stafford Magistrates' Court, following an investigation by the RSPCA.
The charges related to a ewe, two lambs, a Welsh pony, a goat and a pig at the Burton Wildlife and Animal Rescue Centre, a sanctuary founded in 2008 by the 27-year-old nurse in memory of her murdered grandparents.
The pig had made headlines in the Daily Mail in 2012 when Newell rescued it from a Derby council house.
Newell was given a 2-year conditional discharge, ordered to pay £2000 in costs, and disqualified from keeping sheep, equines, goats or pigs for five years.
Passing sentence, district judge David Taylor said: "These were not deliberate or intentional acts. They were a consequence of you trying to take on too many animals of a wide range."
Newell was cleared of 25 other charges of failing to feed the animals in her care properly.
RSPCA inspector Jayne Bashford who led the investigation said: "We are satisfied that the court has found the defendant guilty of six charges of unnecessary suffering. The scene the RSPCA discovered when they visited with Police, Derbyshire Trading Standards and an independent vet were quite shocking.
"This was an extremely disturbing case where there was clear neglect and mistreatment of animals by a registered veterinary nurse.
"I am sure she set up this centre with the best intentions but things got totally out of control."
More on this story
CEVA Animal Health is giving away a key ring torch with every three bottles of Rehydion gel®, its product for scouring calves.CEVA says the deal is to highlight the fact that Rehydion gel® is currently the only oral rehydration treatment that can be added to milk, with guaranteed milk clotting. According to the company, Rehydion gel® has faster, guaranteed milk clotting and helps to maintain a low abomasal pH. Its high palatability and efficient dilution in milk allows weight gain to continue, even in cases of severe scour. It also has a high Strong Ion Difference (SID) which effectively suppresses acidosis. Rehydion gel® is fast to mix by simply shaking the hand-held bottle. Rehydion gel's® consistency means that precise doses of alkalinising agents and electrolytes can be squeeze-delivered with ease. In beef systems the product is time-saving, convenient and minimises stress as it can be given neat, meaning there is need for the calf to be separated from its dam. One bottle provides enough for eight, two-litre calf feeds or 160 feeds for lambs. The distinctive yellow top also acts as a handy measuring cap.
Further information and product literature is available from Martin Gough on 01494 781510.
Baycox Iron Injection is indicated for the concurrent prevention of clinical signs of coccidiosis (such as diarrhoea) in neonatal piglets on farms with a confirmed history of coccidiosis caused by Cystoisospora suis, and the prevention of iron deficiency anaemia.
Professor Nicole Kemper, Director of the Institute for Animal Hygiene, Animal Welfare and Farm Animal Behaviour at the University of Veterinary Medicine Hannover in Germany said: "Piglets go through intense handling in their first days of life. While this is done to give them a better start to life and protect them from disease, it can also cause a lot of stress. Measures to reduce the need for piglet handling can make an important contribution to enhancing piglet well-being in the farrowing pen."
Octavio Orlovsky Eckhardt, Head of Species Marketing Swine at Animal Health, Bayer said: "A combination therapy that can effectively address these concerns with reduced handling can make a real difference for pig health and well-being.
"At the same time, farmers and workers can benefit from the reduced labour. For example, on a 1,000 sow farm, the reduced complexity is estimated to save up to one full work day every month."
For more information on Baycox Iron Injection, contact your local Bayer Animal Health representative.
The independent practice, which was set up in 2010 by husband and wife team Richard and Sophie Aylett, will be a hard act to follow because not only did they achieve awards in all three areas for which they were eligible, but they were marked as "Outstanding" in all three.
For farm practices, the five possible awards are: Team and Professional Responsibility, Client Service, Advisory/Consultancy Service, Diagnostic Service and In-Patient Service. However, as an ambulatory first opinion farm animal practice, Meadows Farm Vets Ltd was only eligible for the first three awards.
Comments from the PSS Assessor included:
"Clinical governance was developing well in the practice. The recording of all surgeries in a file but also in an easy to see chart on the wall, colour coded re follow up was an excellent idea."
"Infection control & biosecurity were taken very seriously and all vehicles were immaculately clean & tidy."
"There was great support provided to new graduates and a comprehensive induction for new team members."
"The resources for farmers including written reports, training meetings, general meetings and comprehensive monthly newsletters were the best I have seen in a farm practice."
"The use and monitoring of a surgical checklist for all surgical procedures was impressive."
Practice Principal Sophie Aylett said: "We are extremely proud to have been recognised by the Royal College for our modern and innovative approach to farm practice. It has been a real team effort in working towards these Awards and we are very excited to be the first farm animal practice to have achieved all three Awards.
"To be marked as “Outstanding” in all three areas is testament to the great team of competent, confident and content vets and staff who are Meadows Farm Vets Ltd."
BVA president-elect John Blackwell has found himself on the front page of The Times today, and interviewed on Radio 4's Today programme, with a call to end the practice of slitting animal's throats and allowing them to bleed to death in order to produce kosher and halal meat.
According to the newspaper, 600,000 animals are killed this way every week in the UK.
Mr Blackwell is urging Jews and Muslims to allow meat-producing animals to be stunned before they are killed.
Speaking to The Times, Mr Blackwell said: "As veterinary surgeons, it is one of the most important issues on our radar. This is something that can be changed in an instant."
See other media reports here.
The company says that the effervescent tablet presentation was designed to significantly improve vaccination practices for poultry producers while maintaining reliable virus protection.
Boehringer says this dispensing form reduces the risk of stock solution contamination and, when compared to glass vials, the small blister packs make vaccine management safer for operators, take up less room in the fridge and reduce packaging waste by 90%.
HatchPak IB H120 NeO will be available shortly in packs of 10 tablets of 1000 doses or 10 tablets of 2000 doses.
Callum Blair, Boehringer Ingelheim Avian and Swine Brand Manager, said: "The addition of HatchPak IB H120 NeO to our NeO product portfolio is evidence of our continued investment in the poultry sector."
Miss Padron Vega faced four charges. The first and second alleged that in February 2016, for the purposes of an application to the Food Standards Agency for a Certificate of Competence under the Welfare of Animals at the Time of Killing Regulations 2015, she backdated two separate veterinary witness certificates to 7 December 2015. The third charge alleged that her acts of backdating were misleading, dishonest and in breach of the RCVS Principles of Certification.
The fourth charge against Miss Padron Vega was that, between September 2015 and February 2016, she failed to fulfil her duties as an Official Veterinarian in respect of: failing to prepare herself for the implementation of the Welfare of Animals at the Time of Killing Regulations 2015; failing to have regard to the information provided to her by her employers about the regulations and their implementation; failing to take any steps to ensure that the two individuals for whom she had given veterinary certification were licensed to perform slaughter in accordance with the regulations; and failing to identify that two individuals were not licensed to slaughter in accordance with the regulations.
The Committee heard that the Welfare at the Time of Killing Regulations were introduced on 5 November 2015 which placed the responsibility on slaughtering operations not to permit animal welfare abuses and required certification by a veterinary witness regarding compliance.
The new regulations required existing slaughter licence holders to apply for a Certificate of Competence before midnight on 8 December 2015 or they would not be permitted to continue operating even with experienced operatives.
During the hearing, Ms Padron Vega admitted charges 1 and 2, admitted that she had been in breach of the Principles of Certification and admitted the fourth charge against her.
However, she denied she had backdated the certificates in a misleading or dishonest way, maintaining that she had done so by mistake.
In considering the facts of the case, however, the Committee rejected this argument and, taking into account that she had been responsible for veterinary certifications in the UK since 2001, found that her conduct was knowingly misleading and dishonest.
The Committee then went on to consider whether the charges she admitted and the charges found against her constituted serious professional misconduct, both individually and cumulatively.
The Committee found that all the charges amounted to serious professional misconduct.
In relation to charge 4 in particular Stuart Drummond, chairing the Committee and speaking on its behalf, said: "The Committee has found that the respondent failed to read even those emails which her employer sent to her which were marked ‘urgent’ or ‘OV importance high’. She must have known that her employers were directing attention to some new statutory scheme for she was provided with PowerPoint slides in that regard which she could read at any time of her convenience. The Committee has been driven to the conclusion that the respondent did not even bother to read those slides for, had she done so, she would have known that she needed to apprise herself of the requirements of the impending new statutory scheme.
"The respondent’s failings in this regard are little short of extraordinary, especially given her obligations as Lead OV for FAI Farms. The total abdication of her responsibility to understand the requirements of the Regulations governing the slaughterhouse operations constitutes, in the judgement of this Committee disgraceful conduct in a professional respect."
The Committee then went on to consider the aggravating and mitigating factors in the case. In terms of aggravating features the Committee noted a lack of insight into the gravity of her conduct, that her conduct undermined in the most serious way public confidence in veterinary certification, and that there were animal welfare implications on her conduct as a number of chickens had to be removed from the slaughterhouse and alternative arrangements made because an auditor from the Food Standards Agency found that it was not compliant.
In mitigation the Committee considered that, despite the potential risk of harm, there was no actual harm occasioned to animals, that Miss Padron Vega has had a long and otherwise unblemished career and no previous issues with the RCVS and that she had admitted some of the charges against her.
Stuart Drummond added: "Ultimately, the Committee was driven to the conclusion that the public’s desire to see the implementation of the highest certification standards in relation to activities which impact on animal welfare and public health, and which did not occur on 3 February 2016, must outweigh this particular veterinary surgeon’s desire and need to continue in practice. This is not a conclusion which the Committee has arrived at lightly. On the contrary, it has reached this decision because it has been driven to the conclusion that it would be failing in its public duty to protect the wider public interest in the maintenance of standards of honesty and right conduct in a member of the profession.
"It is, therefore, the conclusion and decision of this Committee that the only proper sanction that can be imposed in this case is that the respondent’s name should be removed from the Register and it directs the Registrar accordingly."
Miss Padron Vega has 28 days from being informed of the Committee’s decision to lodge an appeal with the Privy Council.
Animalcare has launched Emdocam (meloxicam 20mg/ml), a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class for use in cattle, pigs and horses.
According to the company, Emdocam disrupts the inflammatory cascade by inhibiting prostaglandin synthesis. It is a potent and preferential inhibitor of COX-2, permitting sufficient COX-1 sparing activity. It has analgesic and anti-inflammatory effects. When administered in a single dose to cattle, it has long acting anti-endotoxic, anti-pyretic and anti-inflammatory effects for up to three days.1,2
In cattle, it is indicated for bovine respiratory disease (BRD), clinical mastitis and calf scour. Animalcare says early use of meloxicam for BRD reduces pyrexia and pain, especially in young calves and improves feed intake. Meloxicam plus an antibiotic significantly reduced the extent of lung lesions, leading to improved clinical efficacy and daily liveweight gain in comparison with animals treated with antibiotics alone, for example oxytetracycline,3 florfenicol4and tilmicosin. 5
In the case of clinical mastitis, Animalcare says that used adjunctively with an antibiotic, Emdocam helps relieve local and systemic inflammation, returns the udder to a normal condition and reduces the polymorphonuclear leucocytes (PMN) response. In a large scale, double-blinded study in New Zealand, the addition of meloxicam to antibiotic therapy resulted in lower Somatic Cell Counts and a reduced risk of culling in dairy cows with mild clinical mastitis.6
Calf scour treated with meloxicam, as a supportive therapy, can improve calf well-being and reduce morbidity. In a double-blinded, controlled study, the use of meloxicam improved daily water and feed intake, added greater average bodyweight (bw) gain and helped calves to wean earlier. 7
In horses, administered IV at 3.0ml/100kg bw, Emdocam can be used for musculo-skeletal disorders, as well as colic, resulting in reduced pain and inflammation. In a study of 18 horses comparing flunixin with meloxicam and designed to determine the effect on recovery of ischemic-injured jejunum, meloxicam was found to be a useful alternative for the post-operative treatment of colic. 8
Emdocam is also indicated in pigs for non-infectious locomotive disorders and as an adjunctive therapy with an antibiotic in puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome).
Tony Liepman from Animalcare said: "Emdocam is competitively priced whether used on its own or adjunctively with a long-acting intramuscular (IM) antibiotic, such as Florgane suspension for the treatment of BRD in calves. This, coupled with its long lasting, low volume (2.5ml/100kg bw in cattle), single dose administration, by intravenous (IV) or subcutaneous (SC) injection, makes Emdocam a highly efficacious and practical NSAID."
Emdocam is a POM-V medicine and available as 50 and 100ml multi-dose vials. Withdrawal period in cattle for meat and offal is 15 days and in pigs for meat and offal is 5 days. In horses for meat and offal it is 5 days. In Florgane [POM-V], the withdrawal period for meat and offal is 37 days in cattle and not to be used in cattle producing milk for human consumption
References
Cattle
1,219 farmers took part in the survey: 44% beef and 56% dairy. For the first time, the survey was also tailored for the regions. 488 responses came from famers in England, 380 from Scotland, 164 from Wales and 237 from Northern Ireland.
Boehringer Ingelheim’s Matt Yarnall, who led the project, said: "Headline findings are that farmers have regrets about holding onto persistently infected animals (PIs) which, at the end of the day, no-one should be doing.
"The financial benefit of being free of BVD was estimated as being over £90 per cow per year and when asked what impact BVD has had on their herd, the majority of producers highlighted poor fertility and high levels of disease in the herd.”
Boehringer says the identification of persistently infected animals (PIs) through tag and testing, supported by improved herd biosecurity and vaccination, could cost as little as £10 per cow per year, representing a significant return on investment for a disease with severe financial impact.
Matt said: "Herd biosecurity is also hugely variable. The most commonly selected response was operating a closed herd but, as most practitioners will know, the definition of a true closed herd and the real-life execution of that can be two very different things."
Highlighting one of the other major challenges for producers in cattle-dense areas, results from Scotland that showed that 51% of farmers with neighbouring cattle are worried about their neighbours' BVD status.
Matt said: "Perhaps the most alarming finding was the lack of awareness of the intricacies of some BVD vaccination courses, especially around when they need to be restarted, in order to achieve the protection needed."
2017 survey data from last year showed that 71% of producers were failing to achieve adequate protection when using a BVD vaccine that requires a booster six months after the primary course.
Boehringer says the results showed this is mostly down to not properly understanding the exact nature of the timings for the two-dose primary course, dates of service and calving and then the booster date.
Matt added: "For any practitioner advising clients, the 2018 finding that a shocking 85% haven’t restarted a vaccination course when the majority should have done, should ideally serve as a clear call to action."
For more information about the findings of the National BVD Survey, email bvdzero.uk@boehringer-ingelheim.com.
The Envirobed cubicle bedding study found that cow comfort is farmers' number one priority, rated 'very important' by 89% and 'quite important' by 9%. A close second, scoring 81% 'very important' and 13% 'quite important', was reducing mastitis bugs. Allied to this, number three was high absorbency bedding, scoring 71% and 16% respectively. Farmers taking part used a variety of different bedding materials.
The importance of reducing humidity in cow housing was also well recognised. To improve ventilation, ridge tiles have been removed by 38% and fans installed by 9% of farmers. Another 18% and 10% respectively are considering these two options.
Sally Russell from Envirosystems points out that keeping cows clean and comfortable doesn't need be compromised by this winter's shortage and high cost of bedding straw: "Although this is driving up the cost of sawdust and some other materials, there are exceptions.
"For example, some farmers with beef cattle and dairy replacements in straw yards are using a deep bed of Envirobed Original, made from 100% dried recycled paper. Others place a 15cm layer on the floor and top it off with straw.
"For cubicles, the usual material of choice is EnviroBed Premium, a blend of dried paper and kiln dried virgin wood sawdust. Per cubicle, the recommended daily quantity and cost are just 1kg at less than 10p."
Envirosystems says both materials are 95% dry matter and mildly alkaline 7.4 pH, helping create a dry and comfortable area that is unfavourable to disease organisms and fly eggs. They are also biodegradeable and compatible with all manure systems.
Envirosystems has given the findings of its research to farming unions, Dairy UK and AHDB Dairy with permission to use the data if it helps them promote an accurate and caring image of farming, contrary to misleading propaganda put about all too often by the industry's numerous critics.
Photo: Comfy Cow, copyright Ivor Davey
The company says Euthoxin 500mg/ml is a stronger dose than any other pentobarbital injection products currently available on the UK and Irish markets which means less volume per dose and a better return for veterinary surgeons.
Gareth Carr, commercial manager for Chanelle Vet UK, said: "Our aim is to support UK vets by offering high-quality products at competitive prices.
"We have developed Euthoxin with the veterinarian in mind to offer them a cost-effective, low-volume, reliable euthanasia for a wide spectrum of species."
Euthoxin 500 mg/ml launches officially on 3rd July and will be available from wholesale partners in vials of 100ml.
For further information, download the SPC here, visit www.chanellegroup.co.uk or contact your key account manager for information about a launch offer.
The webinar, which will be streamed live at 8pm on Wednesday 20th November and will be available to watch for six months thereafter, is being presented by James Husband, an RCVS Specialist in cattle health & production.
Topics will include oxidative stress, its impact on cattle performance and the role of trace minerals in immunity and cattle health. The webinar will also cover the current complexities of oral supplementation including absorption and mineral antagonism, along with offering information about the latest innovation to boost trace mineral availability during high demand periods in the production and breeding life cycle.
To register for the webinar, visit: https://www.thewebinarvet.com/pages/register-free-role-trace-minerals-cattle-health-performance-new-veterinary-approach-boost-trace-mineral-availability/
All vets who view the webinar, either live or as a recording on the website, will be able to download a CPD certificate.
The company provides official veterinarians, meat hygiene inspectors and other technical staff to the regulatory compliance sector, and its other clients include Defra, APHA, the Food Standards Agency, DAERA, AHDB, and several private organisations across the UK.
Hallmark says discussions have been ongoing with FSS since mid-2018, since when the company has faced increasing challenges in recruiting and retaining veterinary staff, as a result of eroding salary values and the weakening pound post-Brexit.
David Peace, Chairman of HallMark Meat Hygiene said: "The position we presented to FSS set out HallMark’s case for a substantial increase in funding to apply entirely to frontline veterinary salaries.
"Starting salaries for veterinary staff working with HallMark in this sector had altered very little during the past twenty years. As a responsible employer and trading partner, and with inflation and a weaker pound severely testing real pay levels, HallMark felt it necessary to address those issues robustly and directly to ensure staff are properly compensated and, as a result, that services are stabilised for the benefit of the Scottish meat industry."
"We’re naturally disappointed to part company with a valued customer such as FSS. By mutual agreement last year, we submitted a business case setting out what we believe is necessary to stabilise and maintain service delivery into the future. Ultimately, FSS decided not to accept that business case, and we consequently requested to be released from our contract with them.”
HallMark says it will continue to provide veterinary and technical services to government departments across the UK. Indeed, only last year HallMark’s parent company acquired MLCLS (Meat and Livestock Commercial Services Limited), the leading independent carcase classification business, originally owned by AHDB. HallMark is also an equal partner in its joint venture company, Probita Solutions Limited, which recruits and deploys vets in support of veterinary practices involved in TB testing activities.
The company also says it will continue to bid for major meat sector tenders in the future.
Mr Peace added: "This news should absolutely not be interpreted as a HallMark withdrawal from meat industry official controls. We will continue to offer the same diligence and dedication to welfare and hygiene standards, wherever opportunities arise, and it will be our mission to offer to government the most efficient and professional compliance services possible, optimising the cost of compliance delivery."
A new infographic and educational webinar are now available to share on social media, to increase farmer awareness and provide best practice guidance.
The infographic and webinar explain how vaccination is considered best practice for control of the disease, giving better disease control whilst ensuring responsible use of antibiotics.
Independent sheep veterinary consultant Dr Fiona Lovatt, who leads the cross-industry Sheep Antibiotic Guardian Group, said: "Despite EAE being responsible for over 35% of all abortion diagnoses, only one million of the 3.5 million replacement ewes in the national flock each year are vaccinated against EAE. Any sheep farmer that either buys in ewes for replacements or has close neighbours that also lamb sheep, risks bringing enzootic abortion into their flock.
"Once the disease infects an unvaccinated flock, some ewes are ‘programmed’ to abort at their next lambing, leaving no choice but to put remedial measures in place – usually including both vaccination and antibiotic treatment.
"This means EAE is a disease that, once in a flock, carries high costs both financially and emotionally in terms of lamb losses and farmer stress. Hence it is important that flocks receive appropriate vaccination at least four weeks before ewes go to the ram and avoid the inappropriate use of antibiotics closer to lambing."
Fiona points out that a single dose of EAE vaccine costs about £2.40 and is an investment that effectively lasts the ewe for her lifetime in the flock, protecting against losses. In contrast, abortion or stillbirth – which accounts for around a quarter of all lamb losses each year – costs over £25 for every single lost lamb.
Fiona added: "Every injection of antibiotics also costs an additional £1. But is just a ‘sticking plaster’ with short-lasting effectiveness in terms of disease control but long-lasting damage in terms of mounting resistance."
Ceva says it will continue to work closely with veterinary practices to secure stock of Cevac Chlamydia vaccine to ensure farmers can purchase and use the vaccine at the right time. Ceva also provides subsidised blood sampling for diagnostic purposes.
For further information, call Ceva Animal Health on 01494 781510 or email cevauk@ceva.com.
Photo: Mike Benjamin
Norbrook is expanding its NSAID range with the launch of Loxicom Injection for cattle, pigs and horses.
Norbrook says the new product, which will be available to veterinary surgeons from mid-October, offers treatment for a range of symptoms including pneumonia, acute mastitis and calf scour in cattle, swine locomotor diseases such as lameness and MMA syndrome, acute and chronic musculo-skeletal disorders and equine colic.
Rebecca Pullon, Norbrook Product Manager said: "Loxicom is our tried and trusted NSAID range which has been available in suspension or injection for cats and dogs and which has proven exceptionally popular with veterinary practices. According to the GFK data, Norbrook is the most successful generic manufacturer of Meloxicam, by some distance.
"I am delighted that we can now extend this range to include a Loxicom Injection for Cattle, Pigs and Horses, which I am confident will prove equally as popular."
"As a bio-equivalent product, Loxicom Injection for cattle, pigs and horses is as effective as the pioneer product. There is a misperception that a bioequivalent product is somehow inferior to the pioneer product, which is untrue. In order to attain a license, a company must prove that a bio-equivalent product is at least as effective as the pioneer. With Loxicom Injection for cattle, pigs and horses, it comes with the added reassurance that it has been produced by Norbrook, a world leader in animal health and veterinary pharmaceuticals manufacture."
Containing ceftiofur (50mg/ml) and ketoprofen (150mg/ml), Curacef Duo is presented in a ready-to-use suspension for injection at a low volume dosage – 1 ml/50kg – which is identical to short-acting ceftiofur alone.
Virbac says that Curacef Duo’s combined action can help to minimise production losses in calves and offer a quick return to production for dairy cows affected by bacterial BRD. It can also improve welfare by targeting infection, inflammation and pain all at once, while its ease of use and simple dosing help to increase compliance. Curacef Duo offers a zero milk withdrawal period and an eight day withdrawal period in meat.
Brigitte Goasduf MRCVS, Large Animal Product Manager at Virbac, said: "In creating the first 'two-in-one' combination of two tried and trusted actives, the antibiotic ceftiofur and NSAID ketoprofen, we are offering practitioners an alternative to the treatment of bacterial BRD.
"We believe that the benefits Curacef Duo offers in terms of efficacy, ease of use and action on inflammation and pain, will be valued by both practitioners and farmers."
The company says that CircoMax Myco offers the longest lasting combined protection on the EU market against PCV2 and M. hyopneumoniae pathogens. This reduces the PCV2 viral load in blood and lymphoid tissues, PCV2 fecal shedding, lymphoid tissue lesions associated with PCV2 infection, and lung lesions associated with M. hyopneumoniae infections.
Pig protection was demonstrated against porcine circovirus genotypes 2a, 2b and 2d and lasts for at least 23 weeks after vaccination in fattening pigs for both PCV2 and M. hyopneumoniae.
Monica Balasch, Director, Global Biologicals Development at Zoetis, said: "Porcine circovirus type 2 has demonstrated high mutation and recombination rates and is known to be rapidly evolving in Europe and worldwide. Commercial PCV2 vaccines have been efficacious in controlling the clinical disease, but there is a growing genetic gap between field viruses and vaccines. So far, all vaccines in Europe have been based on one single genotype, PCV2a, while today the most prevalent viruses found belong to other genotypes: PCV2b and especially PCV2d.
“We believe that there is a need for new vaccines, like CircoMax Myco which includes two PCV2 genotypes for a broader coverage. We found excellent results showing reduction of body weight gain losses in field trials in the EU. This innovative one-dose vaccine is a new tool for veterinarians and producers that may improve their PCV2 and M. hyopneumoniae control programs, especially in the face of multi-genotype PCV2 infections.”
Alvaro Aldaz, Director, Global Commercial Development, Swine, Zoetis, said: "For many years, intensive vaccination has contributed to selective pressure and emergence of new PCV2 genotypes. European pig farms are often infected with more than one genotype and subclinical disease is frequent. Commercial vaccines are all based on PCV2a genotype while CircoMax Myco is the first vaccine that includes two PCV2 genotypes (a & b), and the inventive M. hyopneumoniae purified fraction. It is formulated with MetaStim for active immunization, resulting in 23 weeks of protection against these threats."
CircoMax Myco contains inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (ORF2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b ORF2 protein and inactivated Mycoplasma hyopneumoniae, strain P-5722-3.
The group, which was convened by Boehringer Ingelheim, made its recommendation in a poster published at the National Mastitis Council meeting in Arizona1, prior to the launch of Boehringer's new teat sealant, Ubroseal.
The poster added that those animals that are likely to be infected need to receive antibiotic dry cow therapy (ADCT) in addition to a teat sealant.
Boehringer says various studies have shown that using an ITS reduces the risk of new intramammary infections and reduces the risk of clinical mastitis after calving, pointing to a meta-analysis of published papers which showed a 25% reduced risk of new infections and a 29% reduced risk of clinical mastitis for cows receiving ITS plus ADCT compared with ADCT alone
Boehringer’s veterinary adviser, Kath Aplin said: "Against the backdrop of targets from RUMA to reduce antibiotic use in the dairy sector3, adopting ITS for all cows could significantly reduce the need for antibiotics. An increase in the use of ITS is included in the dairy sector targets.
"We estimate that, currently, around 29% of the national herd is dried off without an ITS, so there is huge room for growth4."
Kath added: "With a 300-cow US study showing that a week after drying off, 47% of teats had still not formed a keratin plug5 and a New Zealand study showing that one in 20 cows had teats that remained open for 60 days6, it is clear to see that delayed teat closure is a very real problem in many herds. Teats remaining open after dry off make the udder highly susceptible to infection and delayed teat closure exacerbates the risk of acquiring an intramammary infection post-dry off4."
The expert group also recommended developing a herd plan, classifying herds as low risk or high risk and having a different approach to each.
High risk herds will have had a bulk SCC of >250,000 cell/ml in at least two of the last six months, they may also have a problem with Strep. agalactiae or could be experiencing an unavoidable risk period (a new building for example).
The priority should be to improve udder health management during both the lactation and dry period and any decision to abandon ADCT should be made with care and a full risk assessment.
The group said that in reality, it may be prudent to continue blanket ADCT until udder health has improved.
The group’s recommendations for low risk herds (<250,000 cells/ml in four out of the last six months) were to actively strive towards selective ADCT, supported by ITS for all cows.
The full recommendations are published in the proceedings of the NMC1 or can be obtained from your local Boehringer Ingelheim representative.
Kath said: "It has long been established that the mammary gland is highly susceptible to infection in the dry period and that the majority of clinical mastitis in early lactation is picked up during the dry period.
"Moving towards selective ADCT may not be appropriate immediately for all producers. However, the use of ITS for all cows on all farms will reduce new infection rates, assisting in the drive towards improved udder health and reduced antibiotic use."
Photo: Curious cattle on farmland in Cornwall UK. Shutterstock/Shzphoto
First you need to complete your VetSurgeon Profile, in particular the last four sections: "Qualified at", "Interests", "Interested in collaborating on" (aka goals) and "Memberships".
Then visit VetSurgeon Connect and click the button marked "Share My Location". This will activate the map beneath, allowing you to see local colleagues with common interests. It will also pin you on the map, but only in front of logged in members of the site with whom you have a common interest.
One area of common interest is the connection between general practitioners and referral practitioners. Referral practitioners who have shared their location are pinned on the map and can be seen by general practitioners (who can also filter them by discipline).
It is hoped that this will help create a more vibrant referral marketplace, as it offers referral practitioners who do not have big marketing budgets a way to connect with local general practitioners.
The system also matches VetSurgeon members by a number of other criteria. So for example, if you specify 'Qualified at' in your profile, it will display anyone else who went to the same vet school. If you display a leisure interest like cycling in your profile, it'll display other vets in your area who also like cycling.
If you display a clinical interest, such as oncology, it'll show you others in the area with the same interest.
The same thing happens with 'Interested in collaborating on', which connects you with others working towards the same goals, which can be business goals like practice ownership or a learning goals, such as CPD or being a mentor/mentee.
Lastly, if you specify your membership of a special interest veterinary association, the system will show you other members who are in your area.
VetSurgeon Editor Arlo Guthrie said: "It’s kind of a professional matchmaking service designed to make it easier than ever before for veterinary surgeons and others to hook up and collaborate on all sorts of different things.
"It may be you think you know everyone you need to know in your area already. But so often we think we know people, then find out we didn’t know about a shared passion for something, whether it be a professional or a leisure interest. Indeed, I think the system could be just as useful in connecting members to go on a bike ride together as it is to help them collaborate on CPD or on achieving additional qualifications."
Chris Taylor from Swann-Morton said: "We are really pleased to be part of this initiative which should help to bring the veterinary community closer together through shared experiences and knowledge."
Arlo added: "I’m very grateful for Swann Morton’s support. If you are too, you can show it by visiting the company's website and having a quick browse of the latest products in its veterinary range at www.swann-morton.com."
Bovilis Rotavec Corona is used for the active immunisation of pregnant cows and heifers, 12-3 weeks pre-calving, to raise antibodies against rotavirus, coronavirus and E. coli F5 (K99). Calves gain protection by drinking the fortified colostrum from their vaccinated mothers.
The company says the new license indication will mean greater usage flexibility for UK cattle producers focusing on immunity-led prevention of infectious calf scours.
MSD ruminant veterinary adviser Dr Kat Baxter-Smith said: "On the old license, this vaccine needed to be used within eight hours of opening, so this will be a significant benefit-led change for suckler beef and dairy producers.
"For all-year-round calving dairy herds, for example – that may want to vaccinate successive pregnant dams on different days – it will make an opened bottle of vaccine last much longer. Those running batch calving herds with a long calving period should also benefit. We hope this will help reduce unnecessary wastage of the vaccine on farm and save farmers money.”
MSD says it will still be crucial to store the vaccine properly – upright and refrigerated (at 2-8°C) before and after broaching, and after first use. A broached vial will be able to be used once more during the next 28 days after the first vaccination event and then discarded. Vaccination equipment such as needles and syringes should be sterilized. Use of a multi-dose syringe to minimise vaccine contamination and excessive broaching is recommended.
The vaccine vials should still be shaken well before use. The injection should be made through an area of clean, dry skin with precautions taken against contamination.
Novartis Animal Health UK Ltd has announced the launch of CLiKZiN Pour On for sheep, a short meat withhold period (MWP) product that can be used throughout Spring and Summer for the prevention of blowfly strike in sheep and lambs.
CLiKZiN is a ready-to-use water-based product that protects sheep for eight weeks, and has a meat withhold period of seven days. The product is a line extension of CLiK which offers a longer period of protection at 16 weeks and has a longer withhold period of 40 days. Novartis says that used in conjunction with CLiK, CLiKZiN offers versatile protection throughout the year.
The launch of CLiKZiN comes at the same time that Vetrazin has been reformulated, resulting in a longer meat withhold period for sheep treated with the product.
Thomas Tiley MRCVS from Novartis Animal Health said: "Farmers need reliable protection from the repugnant threat of blowfly strike. CLiKZiN provides eight weeks blowfly prevention together with the trusted performance and safety record associated with CLiK. It also offers the greater flexibility of a seven day meat withhold.
"This makes CLiKZiN ideally suited for a variety of production schedules and stock including lambs for slaughter and pre-shearing ewes."
Blowfly strike can be devastating to sheep, causing severe impact on the welfare of the animal. Within days of a blowfly laying its eggs, clinically normal sheep can be afflicted with flesh eating maggots. This makes prompt and effective treatment critical.
National Sheep Association Chief Executive Peter Morris said: "Fly strike is a terrible burden to the sheep industry both in terms of the welfare of the sheep and economically.
"Having a product available that gives effective prevention against fly strike whilst at the same time having a withdrawal period which does not impinge on the ability of the sheep farmer to market lambs is very welcome. The sheep farmers' armoury against the every day afflictions which affect sheep has been significantly enhanced."